Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: Int J Cancer. 2018 Mar 30;143(3):552–560. doi: 10.1002/ijc.31350

Figure 1.

Figure 1

a. Time to CIN1 regression for IGF2AS (at CpG 5), stratified at median methylation percentage*

*CIN = cervical intraepithelial neoplasia

b. Time to CIN1 regression for Kv DMR, stratified at median methylation percentage*

* CIN = cervical intraepithelial neoplasia; DMR = differentially methylated region (median methylation of all CpG sites)

c. Time to CIN1 regression, stratified at median MEG3 DMR methylation percentage*

* CIN = cervical intraepithelial neoplasia; DMR = differentially methylated region (median methylation of all CpG sites)

d. Time to CIN1 regression, stratified at median PEG10 DMR methylation percentage*

* CIN = cervical intraepithelial neoplasia; DMR = differentially methylated region (median methylation of all CpG sites)